Helus Pharma Inc.
- HELP
- NASDAQ
- Medical - Pharmaceuticals
- Psychedelic Drug Development
$10.55
Today −4.52%Quote Oct 16, 2026, 08:00 PM UTC
−24.75%over the last month
Max drawdown −26.0%From 1-month high −24.8%3 months +48.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$552.0M
Approximate share count
Next earnings
Nov 12
Expected, not confirmed
Analyst target
$22.00
+108.5% from here
Floor
$9.46
10.3% below price
Where the price sits
4 analysts
Analyst range, low to high
$15.00$35.00
- Price $10.55
- Resistance $10.63
- Consensus $22.00
The price is right under resistance. Analysts' average target sits about 109% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about HELPPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Medical - Pharmaceuticals
Employees
100